Viatris Trims FY22 Revenue Outlook, Declares Dividend - Update
(RTTNews) - While reporting financial results for the second quarter on Monday, healthcare company Viatris Inc. (VTRS) trimmed its total revenue guidance for the full-year 2022 to reflect the incremental impact of foreign exchange.
For fiscal 2022, the company no projects total revenue between $16.2 billion and $15.7 billion, down from the prior forecast range of $17.0 billion to $17.5 billion. On average, ten analysts polled by Thomson Reuters expect the company to report revenues of $17.04 billion for the year.
The company also said its Board of Directors declared a 9 percent higher quarterly dividend of $0.12 for each issued and outstanding share of the company's common stock, payable on September 16, 2022, to shareholders of record at the close of business on August 24, 2022.
Viatris Announces US Commercial Launch Of RYZUMVl 0.75%
Viatris Guides FY24 In Line With Estimates - Update
Viatris Reaffirms FY23 Revenue Outlook, Declares Dividend - Update
Viatris Reaffirms FY23 Revenue Outlook, Declares Dividend - Update
Viatris To Acquire Oyster Point And Famy Life Sciences To Create Ophthalmology Franchise
Viatris Reaffirms FY22 Revenue Outlook, Declares Dividend - Update
U.S. District Court Rules In Favor Of Merck In Patent Infringement Suit Against Viatris
